| Literature DB >> 25429258 |
Tali Rosenberg1, Shunit Gal-Ben-Ari1, Daniela C Dieterich2, Michael R Kreutz3, Noam E Ziv4, Eckart D Gundelfinger5, Kobi Rosenblum6.
Abstract
The amount and availability of proteins are regulated by their synthesis, degradation, and transport. These processes can specifically, locally, and temporally regulate a protein or a population of proteins, thus affecting numerous biological processes in health and disease states. Accordingly, malfunction in the processes of protein turnover and localization underlies different neuronal diseases. However, as early as a century ago, it was recognized that there is a specific need for normal macromolecular synthesis in a specific fragment of the learning process, memory consolidation, which takes place minutes to hours following acquisition. Memory consolidation is the process by which fragile short-term memory is converted into stable long-term memory. It is accepted today that synaptic plasticity is a cellular mechanism of learning and memory processes. Interestingly, similar molecular mechanisms subserve both memory and synaptic plasticity consolidation. In this review, we survey the current view on the connection between memory consolidation processes and proteostasis, i.e., maintaining the protein contents at the neuron and the synapse. In addition, we describe the technical obstacles and possible new methods to determine neuronal proteostasis of synaptic function and better explain the process of memory and synaptic plasticity consolidation.Entities:
Keywords: learning; memory consolidation; protein expression; synapse; synaptic stability; translation regulation
Year: 2014 PMID: 25429258 PMCID: PMC4228929 DOI: 10.3389/fnmol.2014.00086
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
Protein synthesis inhibitors and their mechanism of action.
| Protein synthesis inhibitor | Action |
|---|---|
| Anisomycin | 80s peptidyl transferase inhibitor |
| Cycloheximide | Inhibition of eEF2-mediated translocation |
| Diphtheria toxin | Inhibits eEF2 by catalyzing ADP-ribosylation on a diphthamide residue |
| Emetine dihydrochloride | Inhibition of translocation |
| NSC11989 | Preventing the formation of 48s pre-initiation complex |
| Puromycin | Amino-acyl tRNA analog, induces premature termination |
| Salubrinal | Inhibits eIF2α phosphatase |
| 4EGI-1 | Inhibition of eIF4E-eIF4G binding and cap-dependent translation initiation |
Proteasome inhibitors and their mechanism of action.
| Proteasome inhibitor | Action |
|---|---|
| Bortezomib and MG-132 | Reversible inhibition of chymotrypsin-like activity of the 20s subunit and caspase-like activity at higher concentrations. Bortezomib is 50 to 100-fold more potent than MG-132 |
| Lactacystin | Binding to the catalytic core of the 20s subunit, inhibiting all three catalytic activities. Irreversible and fast inhibition of the trypsin and chymotrypsin like catalytic activities |
| Lactacystin clasto-β lactone | The active form of lactacystin |
| Epoxomycin | Binding to the catalytic core of the 20s subunit, inhibiting all three catalytic activities, with higher affinity to the chymotrypsin like catalytic activity |